Hepatic microRNA expression is associated with the response to interferon treatment of chronic hepatitis C
<p>Abstract</p> <p>Background</p> <p>HCV infection frequently induces chronic liver diseases. The current standard treatment for chronic hepatitis (CH) C combines pegylated interferon (IFN) and ribavirin, and is less than ideal due to undesirable effects. MicroRNAs (miR...
Main Authors: | Kuroda Masahiko, Hayashi Katsuyuki, Toyoda Hidenori, Tanaka Masami, Murakami Yoshiki, Tajima Atsushi, Shimotohno Kunitada |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-10-01
|
Series: | BMC Medical Genomics |
Online Access: | http://www.biomedcentral.com/1755-8794/3/48 |
Similar Items
-
Dysregulation of IFN system can lead to poor response to pegylated interferon and ribavirin therapy in chronic hepatitis C.
by: Koji Onomoto, et al.
Published: (2011-01-01) -
The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families.
by: Yoshiki Murakami, et al.
Published: (2011-01-01) -
The roles of microRNA families in hepatic fibrosis
by: Xue-Ping Jiang, et al.
Published: (2017-07-01) -
The Role of MicroRNAs in Response to Interferon Treatment of Chronic Hepatitis C patients
by: Eman El-Ahwany, et al.
Published: (2016-02-01) -
Critical role of interferon-α constitutively produced in human hepatocytes in response to RNA virus infection.
by: Yoji Tsugawa, et al.
Published: (2014-01-01)